SEC Form 4 · accession 0001209191-17-021522
NEKTAR THERAPEUTICS · NKTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roy A Whitfield
Director
Period of report
Mar 15, 2017
Accepted (ET)
Mar 17, 2017 · 6:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000906709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 15, 2017 | M | 14,000 | $8.37 | A | 98,000 | D | |
| Common Stock | holding | — | — | — | 20,000 | I | by Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $8.37 | Mar 15, 2017 | M | 14,000 | D | Sep 15, 2010 | Sep 14, 2017 | Common Stock | 14,000 | 0 | D |